皮肤病学2.0:炎症性皮肤病的精准医学
本文基于免疫学与转录组学进展,将炎症性皮肤病重新定义为由Th17、Th2、Th1、I型干扰素和髓系模块等主导免疫通路驱动的分子实体。作者构建了参考免疫图谱和数字平台,可分析患者皮肤活检的分子谱,辅助临床重叠或诊断模糊皮肤病的精准诊断,并将主导免疫模块与靶向治疗匹配以指导治疗决策。
要点
- 炎症性皮肤病可按主导免疫模块(Th17、Th2、Th1、I型IFN、髓系)进行分子分型。
- 数字平台可分析个体分子谱,辅助诊断临床重叠或诊断模糊的皮肤病。
- 治疗失败多因治疗与免疫模块主导不匹配或模块间免疫漂移,重新对齐可恢复疗效。
核心结论
- 整合分子诊断与免疫模块指导的治疗,可建立优化结局并推进个性化诊疗的精准医学框架。
研究设计与样本
- 研究通过转录组学 delineate 免疫模块并构建参考免疫图谱,开发数字平台用于分析患者皮肤活检分子谱。
主要发现
- 炎症性皮肤病可由Th17、Th2、Th1、I型干扰素和髓系模块等主导免疫通路区分。
- 治疗失败分析显示,治疗与免疫模块主导不一致以及模块间免疫漂移占无应答的大多数情况。
- 使治疗与患者分子谱重新对齐可恢复疗效,并支持现有药物的合理调整或再利用。
临床怎么用
- 临床可借助分子谱分析对临床重叠或诊断模糊的皮肤病进行精准诊断。
- 根据患者主导免疫模块选择最合适的靶向治疗。
- 对治疗无应答者应评估治疗与免疫模块是否不匹配或发生免疫漂移,并据此调整方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Recent advances in immunology and transcriptomics have transformed dermatology, redefining inflammatory skin diseases as distinct molecular entities characterized by dominant immune pathways such as Th17, Th2, Th1, type I interferon (IFN) and myeloid modules. We transcriptionally delineated these immune modules, constructed a reference immune cartography to map patient skin biopsies and developed a digital platform that enables clinicians to analyse individual molecular profiles, facilitating precise diagnosis for clinically overlapping or diagnostically ambiguous dermatoses. Beyond diagnostic utility, this platform supports therapeutic decision-making by aligning each patient's dominant immune module with the most appropriate targeted treatment. Analyses of treatment failures reveal that discordance between therapy and immune module dominance, as well as immune shifts between modules, account for most cases of non-response. Realigning therapy with the patient's molecular profile restores efficacy and enables rational adaptation or repurposing of existing agents. By integrating molecular diagnostics with immune module-guided therapy, this approach establishes a precision medicine framework that optimizes outcomes and advances personalized care for patients with inflammatory skin disease.
引用
- Di Domizio J, Girardin A, Conrad C, et al. Dermatology 2.0: Precision medicine for inflammatory skin diseases. J Eur Acad Dermatol Venereol. 2025. PMID: 41453833. doi:10.1111/jdv.70251
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。